Study of Aldosterone Synthase Inhibition as an Add-On Therapy in Resistant Hypertension
作者： Adam D. Karns , Jacqueline M. Bral , Daniel Hartman , Thomas Peppard , Christoph Schumacher
DOI: 10.1111/JCH.12051
关键词: Eplerenone 、 Aldosterone 、 Medicine 、 Aldosterone synthase 、 Plasma renin activity 、 Mineralocorticoid receptor 、 Adrenal gland 、 Placebo 、 Blood pressure 、 Endocrinology 、 Internal medicine
摘要: Aldosterone inhibition with mineralcorticoid receptor antagonists (MRAs) is an effective treatment for resistant hypertension. Aldosterone synthase inhibitors (ASIs) are currently …
sci-hub.se 参考文章(30)
Gordon H Williams, Ellen Burgess, Rainer E Kolloch, Luis Miguel Ruilope, Joanna Niegowska, Mark S Kipnes, Barbara Roniker, Jeffrey L Patrick, Scott L Krause, Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. American Journal of Cardiology. ,vol. 93, pp. 990- 996 ,(2004) , 10.1016/J.AMJCARD.2004.01.007
Brent M. Egan, Yumin Zhao, R. Neal Axon, Walter A. Brzezinski, Keith C. Ferdinand, Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008 Circulation. ,vol. 124, pp. 1046- 1058 ,(2011) , 10.1161/CIRCULATIONAHA.111.030189
Nancy J Brown, Aldosterone and end-organ damage Current Opinion in Nephrology and Hypertension. ,vol. 14, pp. 235- 241 ,(2005) , 10.1097/01.MNH.0000165889.60254.98
David A. Calhoun, William B. White, Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension Journal of The American Society of Hypertension. ,vol. 2, pp. 462- 468 ,(2008) , 10.1016/J.JASH.2008.05.005
David A. Calhoun, William B. White, Henry Krum, Weinong Guo, Georgina Bermann, Angelo Trapani, Martin P. Lefkowitz, Joël Ménard, Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase 2 Trial Circulation. ,vol. 124, pp. 1945- 1955 ,(2011) , 10.1161/CIRCULATIONAHA.111.029892
Sameer Stas, Adam T. Whaley-Connell, James R. Sowers, Aldosterone and hypertension in the cardiometabolic syndrome. Journal of Clinical Hypertension. ,vol. 10, pp. 94- 96 ,(2008) , 10.1111/J.1751-7176.2008.08082.X
Adam Whaley-Connell, Megan S. Johnson, James R. Sowers, Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Progress in Cardiovascular Diseases. ,vol. 52, pp. 401- 409 ,(2010) , 10.1016/J.PCAD.2009.12.004
Samira Ubaid-Girioli, Leoní Adriana de Souza, Juan Carlos Yugar-Toledo, Luiz Cláudio Martins, Sílvia Ferreira-Melo, Otávio Rizzi Coelho, Cristina Sierra, Antonio Coca, Eduardo Pimenta, Heitor Moreno, Aldosterone excess or escape: Treating resistant hypertension Journal of Clinical Hypertension. ,vol. 11, pp. 245- 252 ,(2009) , 10.1111/J.1751-7176.2009.00110.X
John W. Funder, Anastasia S. Mihailidou, Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology. Molecular and Cellular Endocrinology. ,vol. 301, pp. 2- 6 ,(2009) , 10.1016/J.MCE.2008.10.029
Joël Menard, Catherine Watson, Sam Rebello, Yiming M. Zhang, William P. Dole, HORMONAL AND ELECTROLYTE RESPONSES TO THE ALDOSTERONE SYNTHASE INHIBITOR LCI699 IN SODIUM DEPLETED HEALTHY SUBJECTS Journal of the American College of Cardiology. ,vol. 55, ,(2010) , 10.1016/S0735-1097(10)60584-0